Yonsu Son

14PUBLICATIONS
61CO-AUTHORS
Respiratory diseasesClinical pharmacology and therapeuticsPredictive and prognostic markersMetabolic medicineRheumatology and arthritis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Sep 28, 2026
Renal function-adjusted initial JAK inhibitor dosing and outcomes in rheumatoid arthritis: from the ANSWER cohort study.

|Apr 01, 2026
Clinical outcomes of molecular-targeted therapies for rheumatoid arthritis: comparison between orthopaedic surgeons and rheumatologists in the multicenter retrospective ANSWER cohort.

Yuki Etani, Yasutaka Okita, Kohei Tsujimoto

|Oct 29, 2025
Clinical efficacy of JAK inhibitors for RA patients with poor-prognosis factors: the ANSWER cohort study.

Yuji Nozaki, Koichi Murata, Akira Onishi

|Jul 01, 2025
Differential Impact of Concomitant Methotrexate and Glucocorticoids Dosages on Biologics and JAK Inhibitors: The ANSWER Cohort Study.

Kosuke Ebina, Yuki Etani, Yasutaka Okita

|Mar 20, 2025
Sustained efficacy of second-line JAK inhibitors in patients with rheumatoid arthritis: insights from the ANSWER cohort.

Kohei Tsujimoto, Kosuke Ebina, Satomi Okamura

|Mar 19, 2025
Distinct impact of RF and ACPA titre on the effectiveness and persistency of biologics and JAK inhibitors: The ANSWER cohort study.

Yuki Etani, Yasutaka Okita, Yuichi Maeda

Pageof 3

Frequent Collaborators

13 joint publications

Motomu Hashimoto

13 joint publications

Wataru Yamamoto

12 joint publications

Kosuke Ebina

10 joint publications

Koichi Murata